View More View Less
  • 1 Faculty of Pharmacy and Medical Sciences, Al-Ahliyya Amman University, PO Box 263, Amman, 19328, Jordan
  • | 2 Faculty of Pharmacy, Petra University, PO Box 961343, Amman, Jordan
  • | 3 Faculty of Pharmacy, Zarqa University, Zarqa, 13132, Jordan
  • | 4 Jordan Center for Pharmaceutical Research, PO Box 950435, Amman, 11495, Jordan
Full access

Summary

A simple, sensitive, and precise high-performance liquid chromatographic (HPLC) method for quantitation of montelukast in human plasma has been developed and validated. Commercially available candesartan cilexetil was used as an internal standard. After protein precipitation, montelukast and candesartan cilexetil (I.S.) in human plasma were analyzed using mobile phase containing 62% v/v acetonitrile and 38% v/v buffer (containing 1 mL L−1 triethylamine as peak modifier, final pH adjusted to 2.5 with orthophosphoric acid). Chromatographic separation was achieved on a BDS Hypersil-C18 column (50 × 4.6 mm i.d., particle size 5 μm; Thermo Electron Corporation, USA) using isocratic elution at a flow rate of 1.5 mL min−1. The signals were monitored using a fluorescence detector set at 350 nm for excitation and 400 nm for emission. The total time for a chromatographic separation was ∼3 min. The validated quantitation ranges of this method were 5–300 ng mL−1 with coefficients of variation between 1.75% and 9.38%. Mean recoveries were 91.8 ± 3.8%. The within- and between-batch precisions were 0.74–2.46% and 1.64–7.87%, respectively. The within- and between-batch relative errors (bias) were 0.14–3.3% and 0.08–4.6%, respectively. Stability of montelukast in plasma was >94.7%, with no evidence of degradation during sample processing and 30 days storage in a deep freezer at −70°C. This validated method is sensitive and simple with between-batch precision of <8% and successfully applied for the bioequivalence studies. The formulations were compared using the following pharmacokinetic parameters: AUC0−t, AUC0−∞, and Cmax. No statistically significant difference (p > 0.05) was observed between the logarithmically transformed AUC0−t, AUC0−, and Cmax values.

  • [1]. M. Labelle M. Belley Y. Gareau J.Y. Gauthier D. Guay R. Gordon S.G. Grossman T.R. Jones Y. Leblanc M. McAuliffe C.S. McFarlane P. Masson K.M. Metters N. Ouimet D.H. Patrick H. Piechuta C. Rochette N. Sawyer Y.B. Xiang C.B. Pickett A.W. Ford-Hutchinson R.J. Zamboni R.N. Young 1995 Bioorg. Med. Chem. Lett. 5 283.

    • Search Google Scholar
    • Export Citation
  • [2]. T.R. Jones M. Labelle M. Belley E. Champion L. Charette J. Evans A.W. F.- Hutchinson J.Y. Gauthier A. Lord P. Masson M. McAuliffe C.S. McFarlane K.M. Metters C. Pickett H. Piechuta C. Rochette I.W. Rodger N. Sawyer R.N. Young R. Zamboni W.M. Abraham 1995 Can. J. Physiol. Pharmacol. 73 191.

    • Search Google Scholar
    • Export Citation
  • [3]. B. Knorr J. Matz J.A. Bernstein H. Nguyen B.C. Seidenberg T.F. Reiss A. Becker 1998 JAMA 279 1181.

  • [4]. L.A. Stohlmeyer 1998 J. Pediatr. Health Care 12 324.

  • [5]. K. Malmstrom G. Rodriguez-Gomez J. Guerra C. Villaran A. Pineiro L. Wei B. Scidenberg T. Reiss 1997 Ann. Intern. Med. 130 487.

  • [6]. B. Knorr S. Holland J.D. Rogers H.H. Nguyen T.F. Reiss 2000 J. Allergy Clin. Immunol. 106 171.

  • [7]. H. Bisgaard 2001 Pediatrics 107 381.

  • [8]. Singulair® 2012 Chewable Tablets and Oral Granules (Product Information) Merck & Co., Inc. New Jersey.

  • [9]. H.T. Kim Y.K. Song S.D. Lee Y. Park C.K. Kim 2012 Arzneimittelforschung 62 123.

  • [10]. H. Cheng J.A. Leff R. Amin B.J. Gertz M. D. Smet N. Noonan J.D. Rogers W. Malbecq D. Meisner G. Somers 1996 Pharm. Res. 13 445.

  • [11]. R. Papp P. Luk W.M. Mullett E. Kwong 2007 J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 858 282.

  • [12]. S.K. Balani X. Xu V. Pratha M.A. Koss R.D. Amin C. Dufresne R.R. Miller B.H. Arison G.A. Doss M. Chiba A. Freeman S.D. Holland J.I. Schwartz K.C. Lasseter B.J. Gertz J.I. Isenberg J.D. Rogersm J.H. Lin T.A. Baillie 1997 Drugs Metab. Dispos. 25 1282.

    • Search Google Scholar
    • Export Citation
  • [13]. R.T. Sane A. Menzes M. Mote A. Moghe G. Gandi 2004 J. Planar Chromatogr. 17 75.

  • [14]. I. Alsarra M. Al-Qmar E.A. Gadkariem F. Belal 2005 Il Farmaco 60 563.

  • [15]. R.D. Amin H. Cheng J.D. Rogers 1995 J. Pharm. Biomed. Anal. 13 155.

  • [16]. L. Liu H. Cheng J.J. Zhao J.D. Rogers 1997 J. Pharm. Biomed. Anal. 15 631.

  • [17]. H. Ochiai N. Uchiyama T. Takano K. Hara T. Kamei 1998 J. Chromatogr., B 713 409.

  • [18]. S. Al-Rawithi S. Al-Gazlan W. Al-Ahmadi I.A. Alshowaier A. Yusuf D.A. Raines 2001 J. Chromatogr., B 754 527.

  • [19]. C.J. Kichen A.Q. Wang D.G. Musson A.Y. Yang A.L. Fisher 2003 J. Pharm. Biomed. Anal. 31 647.

  • [20]. G.A. Smith C.M. Rawls R.L. Kunka 2004 Pharm. Res. 21 1539.

  • [21]. P. Sripalakit B. Kongthong A. Saraphanchotiwitthaya J. Chromatogr 2008 B: Anal. Technol. Biomed. Life Sci. 869 38.

  • [22]. G.R. Graff A. Webber D. Wessler-Starman A.L. Smith 2003 J. Pediatr. 142 53.

  • [23]. A. Shafaati A. Zarghi S.M. Foroutan A. Khoddam B. Madadian 2010 J. Bioequivalence Bioavailability 2 135.

  • [24]. US Department of HealthHuman Services 2001 Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation Centre for Drug Evaluation and Research (CDER) Rockville, MD.

    • Search Google Scholar
    • Export Citation
  • [25]. US Department of HealthHuman Services 2003 Food and Drug Administration, Guidance for Industry: Bioavailability and Fed Bioequivalence Studies for Orally Administered Drug Product-General Considerations Centre for Drug Evaluation and Research (CDER) Rockville, MD.

    • Search Google Scholar
    • Export Citation
The author instruction is available in PDF.
Please, download the file from HERE.
 
The Open Access statement together with the description of the Copyright and License Policy are available in PDF.
Please, download the file from HERE.
 

 

Senior editors

Editor(s)-in-Chief: Kowalska, Teresa

Editor(s)-in-Chief: Sajewicz, Mieczyslaw

Editors(s)

  • Danica Agbaba (University of Belgrade, Belgrade, Serbia)
  • Ivana Stanimirova-Daszykowska (University of Silesia, Katowice, Poland)
  • Monika Waksmundzka-Hajnos (Medical University of Lublin, Lublin, Poland)

Editorial Board

  • R. Bhushan (The Indian Institute of Technology, Roorkee, India)
  • J. Bojarski (Jagiellonian University, Kraków, Poland)
  • B. Chankvetadze (State University of Tbilisi, Tbilisi, Georgia)
  • M. Daszykowski (University of Silesia, Katowice, Poland)
  • T.H. Dzido (Medical University of Lublin, Lublin, Poland)
  • A. Felinger (University of Pécs, Pécs, Hungary)
  • K. Glowniak (Medical University of Lublin, Lublin, Poland)
  • B. Glód (Siedlce University of Natural Sciences and Humanities, Siedlce, Poland)
  • A. Gumieniczek (Medical University of Lublin, Lublin, Poland)
  • U. Hubicka (Jagiellonian University, Kraków, Poland)
  • K. Kaczmarski (Rzeszow University of Technology, Rzeszów, Poland)
  • H. Kalász (Semmelweis University, Budapest, Hungary)
  • I. Klebovich (Semmelweis University, Budapest, Hungary)
  • A. Koch (Private Pharmacy, Hamburg, Germany)
  • Ł. Komsta (Medical University of Lublin, Lublin, Poland)
  • P. Kus (Univerity of Silesia, Katowice, Poland)
  • D. Mangelings (Free University of Brussels, Brussels, Belgium)
  • E. Mincsovics (Corvinus University of Budapest, Budapest, Hungary)
  • G. Morlock (Giessen University, Giessen, Germany)
  • A. Petruczynik (Medical University of Lublin, Lublin, Poland)
  • J. Sherma (Lafayette College, Easton, PA, USA)
  • R. Skibiński (Medical University of Lublin, Lublin, Poland)
  • B. Spangenberg (Offenburg University of Applied Sciences, Germany)
  • T. Tuzimski (Medical University of Lublin, Lublin, Poland)
  • Y. Vander Heyden (Free University of Brussels, Brussels, Belgium)
  • A. Voelkel (Poznań University of Technology, Poznań, Poland)
  • B. Walczak (University of Silesia, Katowice, Poland)
  • W. Wasiak (Adam Mickiewicz University, Poznań, Poland)

 

KOWALSKA, TERESA
E-mail: kowalska@us.edu.pl

SAJEWICZ, MIECZYSLAW
E-mail:msajewic@us.edu.pl

Indexing and Abstracting Services:

  • Science Citation Index
  • Sci Search
  • Research Alert
  • Chemistry Citation Index and Current Content/Physical
  • Chemical and Earth Sciences
  • SCOPUS
  • GoogleScholar
  • Index Copernicus
  • CABI
2020
 
Total Cites
650
WoS
Journal
Impact Factor
1,639
Rank by
Chemistry, Analytical 71/83 (Q4)
Impact Factor
 
Impact Factor
1,412
without
Journal Self Cites
5 Year
1,301
Impact Factor
Journal
0,34
Citation Indicator
 
Rank by Journal
Chemistry, Analytical 75/93 (Q4)
Citation Indicator
 
Citable
45
Items
Total
43
Articles
Total
2
Reviews
Scimago
28
H-index
Scimago
0,316
Journal Rank
Scimago
Chemistry (miscellaneous) Q3
Quartile Score
 
Scopus
393/181=2,2
Scite Score
 
Scopus
General Chemistry 215/398 (Q3)
Scite Score Rank
 
Scopus
0,560
SNIP
 
Days from
58
submission
 
to acceptance
 
Days from
68
acceptance
 
to publication
 
Acceptance
51%
Rate

2019  
Total Cites
WoS
495
Impact Factor 1,418
Impact Factor
without
Journal Self Cites
1,374
5 Year
Impact Factor
0,936
Immediacy
Index
0,460
Citable
Items
50
Total
Articles
50
Total
Reviews
0
Cited
Half-Life
6,2
Citing
Half-Life
8,3
Eigenfactor
Score
0,00048
Article Influence
Score
0,164
% Articles
in
Citable Items
100,00
Normalized
Eigenfactor
0,05895
Average
IF
Percentile
20,349
Scimago
H-index
26
Scimago
Journal Rank
0,255
Scopus
Scite Score
226/167=1,4
Scopus
Scite Score Rank
Chemistry (miscellaneous) 240/398 (Q3)
Scopus
SNIP
0,494
Acceptance
Rate
41%

 

Acta Chromatographica
Publication Model Online only
Gold Open Access
Submission Fee none
Article Processing Charge 400 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

Acta Chromatographica
Language English
Size A4
Year of
Foundation
1992
Volumes
per Year
1
Issues
per Year
4
Founder Institute of Chemistry, University of Silesia
Founder's
Address
PL-40-007 Katowice, Poland, Bankowa 12
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2083-5736 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Aug 2021 0 4 1
Sep 2021 0 5 5
Oct 2021 0 1 1
Nov 2021 0 6 5
Dec 2021 0 3 1
Jan 2022 0 2 1
Feb 2022 0 0 0